
TLX
Telix Pharmaceuticals
$9.98
−$0.24 (−2.35%)Jul 27, 2026
Key metrics
The numbers that frame TLX today
- Market cap
- $3.38B
- P/E (TTM)
- -683.3
- EV / FCF
- -120.8
- Gross margin
- 53.1%
- EV / Sales
- 6.5
- ROIC
- 5.5%
- Div yield
- 0%
- Debt / equity
- 1.1
- 52wk Low
- $6.28
- 52wk High
- $14.27
Growth
Revenue and earnings trend for TLX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about TLX
Is Telix Pharmaceuticals a good buy?
Yes. Telix Pharmaceuticals has excellent quality and mixed momentum. Taken together, the setup leans positive. We think Telix Pharmaceuticals is selling at a high price, which cuts against the buy case.
What is the market capitalization of TLX?
Telix Pharmaceuticals's market capitalization is $3.38B.
What is the P/E ratio for TLX stock?
Telix Pharmaceuticals's current P/E ratio is -683.3.
What is the 52-week high for TLX stock?
The 52-week high for Telix Pharmaceuticals is $14.27. The current close of $9.98 is 30.1% below that high.
What is the 52-week low for TLX stock?
The 52-week low for Telix Pharmaceuticals is $6.28. The current close of $9.98 is 58.9% above that low.
Does TLX stock pay dividends?
Telix Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for TLX?
Telix Pharmaceuticals's Debt / Equity ratio is 1.13.